Original Medscape Article
By Will Boggs, MD
NEW YORK (Reuters Health) Dec 23 - The incidence
of kidney cancer has increased significantly over the past three decades
in the United States, according to a report in the November 16 online
issue of The Journal of Urology.
"As imaging tests are ordered for a variety of
reasons, incidental renal cancers are being increasingly found," Dr.
Seth A. Strope from Washington University School of Medicine in St.
Louis, Missouri, told Reuters Health by email.
"Since most of these tumors are now found in an
asymptomatic state, internists should be vigilant for these findings on
their scans."
Dr. Strope and colleagues used National Cancer
Institute SEER cancer registry data for 1975 to 2006 to determine the
kidney cancer incidence by age.
During this interval, the overall age-adjusted
kidney cancer incidence increased 238%, from 7/100,000 to 17.6/100,000
adults. The annual rise was higher between 1976 and 1990 (3.6% annually)
than between 1991 and 2006 (2.9% annually).
Renal tumors diagnosed after 1991 were more likely to be smaller and localized to the kidney than tumors diagnosed earlier.
All age groups showed an increase in renal cancer
diagnoses during the more contemporary periods, with the most rapid
increases appearing in the younger age groups during the second half of
the study.
The fastest increase in renal cancer incidence
was in the 20- to 39-year-old group, followed by the 60-to-69- and
70-to-79-year-old groups.
"The trend toward increased exposure to risk
factors for kidney cancer at earlier ages combined with imaging may help
explain why the youngest age group had the fastest increase in renal
cancer relative to the other age groups," the researchers note.
"Rising incidence of kidney cancer points to the
need to appropriately tailor therapy to individual patients," Dr. Strope
said. "Younger patients would most benefit from kidney preservation
through removal of only the tumor, while older patients may benefit from
surveillance of small renal masses."
"Further research into the rising incidence of
kidney cancer will need to focus on new risk factors," Dr. Strope added.
"Exploration of large cohort studies with focus on risk factors in past
versus more current years will be needed to determine these risk
factors."
SOURCE: http://bit.ly/s3edud
J Urol 2011;187:32-38.
No comments:
Post a Comment